| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 09/18/2008 | US20080226606 Polypeptide comprising major histocompatibility complex epitopes for use in targeting and destroying tumor cells |
| 09/18/2008 | US20080226601 Herpes Virus-Based Compositions and Methods of Use in the Prenatal and Perinatal Periods |
| 09/18/2008 | US20080226599 Methods of treatment involving p21/CIP1 |
| 09/18/2008 | US20080226598 Dendritc specific RNA viral plasmid comprising nucleotide sequences coding tumor associated for use in developing cancer vaccine; genetic vaccines |
| 09/18/2008 | US20080226558 Mesoderm and definitive endoderm cell populations |
| 09/18/2008 | US20080226556 Using macrophages;milk fat globulins; epidermal growth factor mutants |
| 09/18/2008 | US20080226553 Transfection of stem cells; cell proliferation |
| 09/18/2008 | CA2688121A1 Markers, antibodies and recombinant scfvs for mesenchymal stem cell-sub-populations and osteoclasts |
| 09/18/2008 | CA2681096A1 Oncolytic vaccinia virus cancer therapy |
| 09/18/2008 | CA2680600A1 Li-rnai involved li suppression in cancer immunotherapy |
| 09/17/2008 | EP1970449A1 Attenuated salmonella SPI2 mutants as antigen carriers |
| 09/17/2008 | EP1970448A1 Human artificial chromosome containting human antibody lambda light chain and non-human animal containting the human artificial chromosome capable of genetic transmission |
| 09/17/2008 | EP1970386A2 Hybrid immunoglobulins |
| 09/17/2008 | EP1970078A1 Composition inhibiting the expression of target gene in eyeball and remedy for disease in eyeball |
| 09/17/2008 | EP1970075A1 THERAPEUTIC AGENT FOR NEUROBLASTOMA TARGETING ARID3b |
| 09/17/2008 | EP1970072A1 Use of GLP-2 peptides for the treatment of hyperparathyroidism |
| 09/17/2008 | EP1970058A1 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs |
| 09/17/2008 | EP1969126A1 Method of detecting and reducing boar taint using nuclear receptors |
| 09/17/2008 | EP1969000A2 Cell penetrating peptides for intracellular delivery of molecules |
| 09/17/2008 | EP1968545A2 Medicament for topical use |
| 09/17/2008 | EP1968386A2 Method for treating immune dysfunction by regulation of cd40 ligand expression |
| 09/17/2008 | EP1526840B1 Nanoparticles for dna administration to a target organ |
| 09/17/2008 | EP1284999B1 Repair of nerve damage |
| 09/17/2008 | EP1141331B1 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 09/17/2008 | EP1121434B1 Polypeptides for modulating cell survival |
| 09/17/2008 | EP1009440B1 Method for inhibiting immunostimulatory dna associated responses |
| 09/17/2008 | CN101267805A Systems and methods for manufacturing liposomes |
| 09/17/2008 | CN101265484A Method for constructing pacing channel gene hypotype HCN2 recombination slow virus vector |
| 09/17/2008 | CN101265482A Recombination tumor chalone-tumor putrescence factor secretion type eukaryon expression vector and its preparation method and use |
| 09/17/2008 | CN101265285A Immunostimulatory nucleic acid molecules |
| 09/17/2008 | CN101264324A Blocking immune response to a foreign antigen using an antagonist which binds to CD20. |
| 09/17/2008 | CN101264062A Production technology for preparing freeze-drying genetic engineering bacterium competence cell and protective agent formula |
| 09/17/2008 | CN100418583C Medicine composition for preventing and treating mammitis |
| 09/17/2008 | CN100418582C Microcapsule for promoting bone regeneration and its use |
| 09/16/2008 | US7425645 Ester-linked gemini surfactant compounds for use in gene therapy |
| 09/16/2008 | US7425623 Binding to surface of tumor cell; bacteriophage separation; in situ diagnosis |
| 09/16/2008 | US7425617 Antibodies to the cell cycle regulatory protein p16 |
| 09/16/2008 | US7425610 Expression vector comprising nucleotide sequences coding novel receptor protein for use in prevention and treatment of cell proliferative and autoimmune disorders |
| 09/16/2008 | US7425545 Antisense oligonucleotide for use in controlling c-reactive protein expression and treatment and prevention of adipocyte differentiation, obesity, hyperlipidemia, atherosclerosis and hypertension |
| 09/16/2008 | US7425543 Microencapsulated materials and method of making same |
| 09/16/2008 | US7425531 Administering bone polypeptide-1 expressed by a nucleic acid for treating a bone disorder or osteoporosis of a patient |
| 09/16/2008 | US7425449 Site specific Listeria integration vectors and methods for using the same |
| 09/16/2008 | US7425444 Genome sequences and nucleotide sequences coding for the PWD circovirus polypeptides, such as the circovirus structural and non-structural polypeptides, vectors including the sequences, and cells transformed by the vectors |
| 09/16/2008 | US7425443 Treatment of diabetes with synthetic beta cells |
| 09/16/2008 | US7425429 Method for the identification of tissue-specific regulatory sequences |
| 09/16/2008 | US7425424 Combining a labelled test compound with an isolated cell from the spleen, lymph node, thymus or a B-cell lymphocyte comprising a heterlogous polypeptide; determining kinase activity; drug screening, medical diagnosis; genetic engineering |
| 09/16/2008 | US7425338 Clostridial toxin derivatives and methods for treating pain |
| 09/16/2008 | US7425337 Alphavirus replicon vector systems |
| 09/16/2008 | US7425334 immunization of non-human animals to generate polyclonal antibodies against Nogo proteins, comprising administering an immunogenic protein that is free of all central nervous system myelin and recovering polyclonal antibodies from the animal |
| 09/16/2008 | US7425327 Choline binding proteins for anti-pneumococcal vaccines |
| 09/12/2008 | WO2008109839A1 Cardiac-specific progenitor cells |
| 09/12/2008 | WO2008109837A2 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell |
| 09/12/2008 | WO2008109794A2 The role of the mk2 pathway in treating fibrosis and scarring |
| 09/12/2008 | WO2008109779A2 Use of follistatin-like related gene (flrg) to increase muscle mass |
| 09/12/2008 | WO2008109432A2 Therapeutic targeting of interleukins using sirna in neutral liposomes |
| 09/12/2008 | WO2008109398A1 T4 bacteriophage bound to a substrate |
| 09/12/2008 | WO2008109142A2 Pirna and uses related thereto |
| 09/12/2008 | WO2008109105A2 Methods and compositions for improved therapeutic effects with sirna |
| 09/12/2008 | WO2008109083A2 Restrictive agonist of toll-like receptor 3 (tlr3) |
| 09/12/2008 | WO2008108344A1 Cell for gene therapy of lcat deficiency, and replication-deficient retrovirus vector and plasmid for use in the production of the cell |
| 09/12/2008 | WO2008107900A2 Compositions and methods for modulating cell migration |
| 09/12/2008 | WO2008107462A2 Plasmid containing a sequence encoding a disintegrin domain of metargidin (rdd) |
| 09/12/2008 | WO2008107422A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/12/2008 | WO2008106796A1 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity |
| 09/12/2008 | WO2008106781A1 Treatment of squamous cell carcinoma with hsp27 antisense oligonucleotides and radiotherapy |
| 09/12/2008 | WO2008089329A9 Novel activation and transfer cascade for ubiquitin |
| 09/12/2008 | WO2006121454A3 Use of mapc or progeny therefrom to populate lymphohematopoietic tissues |
| 09/12/2008 | CA2680202A1 Pirna and uses related thereto |
| 09/12/2008 | CA2680129A1 Method for expression of small antiviral rna molecules with reduced cytotoxicity within a cell |
| 09/12/2008 | CA2680114A1 Plasmid containing a sequence encoding a disintegrin domain of metargidin (rdd) |
| 09/12/2008 | CA2680058A1 Induction of apoptosis and inhibition of cell proliferation through modulation of carnitine palmitoyltransferase 1c activity |
| 09/12/2008 | CA2679545A1 Osteopontin for the prediction and treatment of cardiovascular diseases |
| 09/11/2008 | US20080222742 Plasmid comprising ribosmal protein promoter sequences for use as tool in controlling and enhancing genic expression in transgenic cells; biodrug |
| 09/11/2008 | US20080221317 siRNA targeting cystic fibrosis transmembrane conductance regulator (CFTR) |
| 09/11/2008 | US20080221058 Tumor-Specific Vector for Gene Therapy |
| 09/11/2008 | US20080221054 In vitro; transgenic cells, mammals; kits |
| 09/11/2008 | US20080221051 Gene expression inhibition; sustained release; for reduction of neuronal cell death, inflammation, and scar formation; improves wound healing, skin rejuvenation and thickening |
| 09/11/2008 | US20080221036 Use of AGT and its derivatives for manufacturing anti-angiogenesis pharmaceutical compositions |
| 09/11/2008 | US20080221034 Canine specific growth hormone releasing hormone |
| 09/11/2008 | US20080220527 Modular transfection systems |
| 09/11/2008 | US20080220500 Expression vector comprising nucleotide sequences coding lipogenic enzyme for treatment and prevention of cardiovascular, inflammatory, nervous system, gastrointestinal and psychological disorders |
| 09/11/2008 | US20080220072 Biologic modulations with nanoparticles |
| 09/11/2008 | US20080220007 Ehrlichia canis genes and vaccines |
| 09/11/2008 | US20080219991 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219990 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219989 Nucleotide sequences coding tumor polypeptides for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 09/11/2008 | US20080219988 Polypeptide comprising major histocompatibility complex epitopes for targeting and destroying tumor cells |
| 09/11/2008 | US20080219986 Neisserial protein for use in diagnosis, prevention and treatment of microorganismal infection |
| 09/11/2008 | US20080219982 Compositions and methods for the therapy and diagnosis of breast cancer |
| 09/11/2008 | US20080219981 Solid cancer antigenic polypeptide for use in designing and identifying modulators for prevention and treatment of tumorous masses |
| 09/11/2008 | US20080219957 Propagating embryonic stem cells nutrient broth comprising fibroblast growth factor, recovering mesenchymal tissues and using cells to treat skin, bone, cardiac and nervous system disorders; tissue engineering; tissue repair; regenerative medicine |
| 09/11/2008 | US20080219954 Viral vector comprising adenovirus capsid gene sequences for use as tool for delivery and expression of heterologous gene sequences in cells |
| 09/11/2008 | US20080219953 Cosmid dna constructs and methods of making and using same |
| 09/11/2008 | US20080219924 Imaging, diagnosis and treatment of disease |
| 09/11/2008 | DE102007011702A1 Aptamer-basierte Reagenzien Aptamer-based reagents |
| 09/10/2008 | EP1967586A1 84P2A9: A prostate and testis specific protein highly expressed in prostate cancer |
| 09/10/2008 | EP1967525A2 A method for regulating immune function in primates using the foxp3 protein |
| 09/10/2008 | EP1967206A2 Anti-IgE vaccines |
| 09/10/2008 | EP1967205A2 Anti-IgE vaccines |
| 09/10/2008 | EP1966384A2 Viral vectors |